Market Overview

Brightview Holdings Has 14% Upside Potential, Stifel Says In Bullish Initiation

Brightview Holdings Has 14% Upside Potential, Stifel Says In Bullish Initiation

Brightview Holdings Inc (NYSE: BV) is an appropriate stock for investors who can accept moderate returns in in the face of moderate risk, according to Stifel.

The Analyst

Stifel's Shlomo Rosenbaum initiated coverage of Brightview with a Buy rating and $25 price target.

The Thesis

Brightview's stock traded on the public market for the first time in late June; the company is roughly nine times bigger than its closest competitor in revenue terms and boasts an acquisition pipeline that represents around $200 million of EBITDA, Rosenbaum said in the initiation note. (See the analyst's track record here.) 

Brightview's already large size puts it in a position where it can pursue even more acquisitions at a faster pace, which should generate superior margins over the longer term, the analyst said. 

Stifel projects a 2-3-percent organic growth rate for Brightview, in-line with the industry average. M&A deals can lift the company's total growth rate to the mid-single digits, the analyst said. Investors can expect the stock to move higher over time, although seasonal fluctuations in weather could create volatility, Rosenbaum said.  

A realistic downside case is $20 per share, which implies a drop of around 9 percent but would still value the stock at a premium valuation versus some peers, the analyst said. 

The stock's risk-reward profile is "skewed somewhat upwards," and the shares have upside potential to $25 per share if future acquisitions generate incrementally higher accretion versus expectations, according to Stifel. 

Price Action

Brightview Holdings shares were trading higher by 0.91 percent at the time of publication Monday afternoon at $22.15. 

Related Links:

10 Stocks To Watch For July 23, 2018

A Peek Into The Markets: US Stock Futures Down; Alphabet Earnings In Focus

Latest Ratings for BV

Nov 2019DowngradesBuyHold
Nov 2019MaintainsOutperform
Jul 2019DowngradesOverweightNeutral

View More Analyst Ratings for BV
View the Latest Analyst Ratings

Posted-In: Shlomo Rosenbaum StifelAnalyst Color Price Target Initiation Analyst Ratings Best of Benzinga


Related Articles (BV)

View Comments and Join the Discussion!

Latest Ratings

ZYMEJP MorganInitiates Coverage On43.0
CWEBCompass PointInitiates Coverage On15.9
BZUNHSBCInitiates Coverage On41.5
ETNBBank of AmericaInitiates Coverage On33.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Biogen Q2 Earnings Preview

Upcoming Earnings: Alphabet's $5 Billion Fine to Weigh on Results